Gallic acid in labisia pumila has been clinically proven to reduce visceral fat accumulation and waist circumference in both men and women, after just 40 days of twice daily supplementation in 125mg doses [1].

Every capsule of Labeesity® contains SKF7™, the Standardized Herbal Extract of the labisia pumila plant which contains a standardized minimum of 4.5% gallic acid. SKF7™ is the most significant compound in Labeesity® in promoting weight loss.

Gallic acid and other multiple compounds in Labeesity® work synergistically to achieve weight loss by:

- Blocking fat accumulation and formation in the body by inhibiting adipogenesis, the formation of adipocytes or fat cells from stem cells

- Inhibiting the expansion or multiplication of fat cells by preventing vessel growth to adipose or fat tissue

- Blocking absorption of some dietary fat by the body by mildly inhibiting the pancreatic lipase enzymes

- Regulating appetite, which results in lower food consumption and caloric intake.

Labeesity® is recommended for adults who are overweight or obese, or with a BMI of 25 or higher, as well as those who wish to maintain their weight. It is not recommended for pregnant and breastfeeding women. If you are already on medication for other health issues, please consult your doctor before consuming Labeesity®.

Labeesity® is on its way to being classified as a botanical therapeutic drug; so it is in a class on its own, above other dietary supplements.

Unlike manufacturers of other dietary supplements, who usually conduct studies on non-diseased individuals, SKF7™, the key ingredient in Labeesity®, has undergone rigorous clinical and pre-clinical trials. It is currently undergoing multi-center in-human clinical trials in order to be classified as a botanical drug. SKF7™ is being subjected to the gold standard of research, the same exacting standards required of medical pharmaceuticals.

Dietary supplements that do not undergo these rigorous tests cannot legally claim to be able to treat or prevent diseases.

Each Labeesity® capsule is tested at every stage of the manufacturing process using the proprietary PhytoProfile™ technology to ensure it contains the required quantities and combinations of bio-active compounds for maximum efficacy. The technology also ensures that safety standards are also adhered to.

The key ingredient in Labeesity® is SKF7™, the Standardized Herbal Extract derived from the labisia pumila plant. The first Malaysian-made bio-extract to be recognized by the United States FDA (US FDA), SKF7™ contains several bio-active compounds that have been scientifically proven to aid weight loss [1].

Each capsule of Labeesity® contains the Standardized Herbal Extract of labisia pumila (SKF7™), a minimum of 4.5% gallic acid, vegetable capsule and maltodextrin.

Labisia pumila, also known as Kacip Fatimah in Malaysia, is a flowering plant that is indigenous to Malaysia, Indonesia and other parts of the Southeast Asian region. The plant has been used in traditional medicine in Malaysia and Indonesia for generations [2], particularly in treating issues concerning women’s reproductive health.

The bio-active compounds contained in labisia pumila that are responsible for its remedial properties have recently been identified, extracted and standardized for consumption. One of the compounds is gallic acid (3,4,5-trihydroxybenzoic acid), which is high in antioxidants, contains antibacterial and anti-inflammatory properties, and has been proven to effectively promote weight loss [1].

A dietary ingredient is a vitamin, mineral, herb, botanical, amino acid, or dietary substance to supplement the diet by increasing total dietary intake, or a concentrate, metabolite, constituent, extract, or combination of any of the above dietary ingredients.

The term New Dietary Ingredient (NDIN) refers to a dietary ingredient that was not marketed in the United States in a dietary supplement before October 15, 1994. A product containing the dietary ingredient must be a dietary supplement.

Dietary supplement means a product, other than tobacco, intended to supplement the diet that contains one or more dietary ingredients, which are not conventional foods or a sole item of a meal or diet [3].

SKF7™ was approved by the United States FDA as a NDIN in 2020.

PhytoProfile™ is Medika Natura’s proprietary technology which enables stringent quality control to be performed on all its products, including Labeesity®. Formerly known as Orchid Life, Medika Natura is the company responsible for developing, manufacturing and commercializing SKF7™ and Labeesity®. PhytoProfile™ enables end-to-end phytochemical profiling and DNA fingerprinting to ensure the utmost quality, safety and integrity of components and ingredients, in every product manufactured by the company.

In addition to aiding weight loss, labisia pumila has also been proven to promote:

- Reproductive health: for relieving symptoms of menopause and estrogen-deficiency related diseases including irritability, anxiety, insomnia and osteoporosis [1] [2] [3].

- Cardiovascular health: suppress bad cholesterol as well as manage vascular stiffness to prevent atherosclerosis and its associated diseases, including heart attacks, strokes, and peripheral artery disease [4] [5] [6].

- Diabetes: increases insulin sensitivity and sugar uptake levels, reducing the risk of metabolic syndrome and type 2 diabetes [6].

- Anti-aging: promotes skin collagen synthesis, while also safeguarding against the photo-aging and oxidative effects of sun exposure [7].

Labeesity® is manufactured by Medika Natura (formerly known as Orchid Life), a producer of safe and clinically proven botanical bio-active compounds for the pharmaceutical, nutraceutical and cosmeceutical industries.

Labeesity® is available in dosages of 60mg and 125mg. There are two variations of the 125mg packaging, containing 30 capsules and 60 capsules respectively. Information on the recommended daily consumption can be found on the product box.